DBV Technologies | DBVT - 負債





負債 変化する 日付
Acadia Pharmaceuticals USD 52.19M 2.62M 2025-12
Alnylam Pharmaceuticals USD 1.28B 30.06M 2025-12
Amarin USD 0 0 2025-03
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
DBV Technologies USD 8.59M 295K 2025-09
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Galectin Therapeutics USD 71.74M 10.6M 2023-12
Halozyme Therapeutics USD 2.14B 2.01M 2026-03
Incyte USD 39.43M 982K 2026-03
Insmed USD 727.62M 275K 2026-03
Ionis Pharmaceuticals USD 2.34B 9.5M 2026-03
Neurocrine Biosciences USD 406.2M 9.1M 2026-03
PTC Therapeutics USD 286.94M 2.42B 2026-03
Sarepta Therapeutics USD 1.04B 210.44M 2025-12
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
United Therapeutics USD 200M 100M 2025-03